Eczema physical examination

Revision as of 01:18, 26 May 2022 by Edzelco (talk | contribs)
Jump to navigation Jump to search

Eczema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eczema from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Social Impact

Future or Investigational Therapies

Case Studies

Case #1

Eczema On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eczema

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eczema

CDC on Eczema

Eczema in the news

Blogs on Eczema

Directions to Hospitals Treating Eczema

Risk calculators and risk factors for Eczema

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.


Overview

Eczema is a [dermatologic disease]] and pruritus is the hallmark feature of this disease. [1] [2]

Physical Examination

Table 1. Summary of Physical Examination.
System Findings
General Appearance Patient with eczema usually appears conscious, coherent, and not in cardiorespiratory distress.
Vital Signs Patient is usually normotensive and afebrile.
HEENT Head can be normocephalic.
Eyes can be normal.
Ears can be normal.
Nose can be normal.
Throat can be normal.
Chest / Lungs Respiration can be normal.
Cardiovascular Patient usually has no pertinent findings.
Abdomen Patient usually has no pertinent findings.
Skin / Extremities
More severe eczema



A patch of eczema that has been scratched
Neurologic Patient usually has no pertinent findings.


References

  1. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1016/j.jaad.2013.10.010. doi: 10.1016/j.jaad.2013.10.010. Check |pmid= value (help).
  2. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID http://dx.doi.org/10.1016/j.cpha.2016.06.004. doi: http://dx.doi.org/10.1016/j.cpha.2016.06.004. Check |pmid= value (help).